CDC advisers recommend who can get Pfizer booster shots
Third doses of the Pfizer vaccine could be available to seniors and other at-risk groups this week.
FDA authorizes Pfizer COVID-19 booster shots for some
Third doses could roll out this week, pending a review by CDC advisers
Frequently asked questions about COVID-19 and kids
When can kids get vaccinated? Are Delta variant symptoms worse?
States push for more monoclonal antibodies to treat COVID-19
Some states fear their need for the potentially lifesaving treatment will outpace allocations from the federal government.
FDA advisers endorse Pfizer booster shots for elderly, high-risk Americans
The panel had initially rejected by a majority vote over Pfizer's request for full approval of a booster.
Researchers to study "long COVID" in thousands of survivors
Some COVID-19 "long-haulers" report struggling with debilitating symptoms for months after their initial infection.
Unvaccinated people 11 times more likely to die from COVID, CDC says
Three studies published by the agency show booster shots could be needed soon.
Vaccine effectiveness against hospitalization falls for oldest patients
Effectiveness in preventing hospitalization dropped to 80% among patients at least 75 years of age.
What to know about COVID-19 as fall approaches
Answers to some of the frequently asked questions about the virus, breakthrough infections and booster shots.
FDA grants Pfizer's COVID-19 vaccine full approval
Health officials hope the move could help reverse the nationwide slowdown in vaccinations.
Decision over Johnson & Johnson boosters could take weeks
Both the drug maker and an NIH trial could have results for recipients of the single-shot vaccine soon.
CDC reports decline in vaccine effectiveness, prompting booster decision
The vaccines appear to remain effective against severe illness or hospitalization from COVID-19 for most people.
COVID-19 symptoms and the Delta variant
U.S. scientists are investigating whether fully vaccinated people are experiencing different symptoms with the Delta variant than with prior variants.
FDA expected to allow third vaccine dose for some immunocompromised Americans
News of the move comes as the CDC's independent panel of vaccine advisers is scheduled to meet Friday morning to discuss "additional doses in immunocompromised individuals."
New vaccinations have nearly doubled from last month
The country was averaging around 441,198 new vaccinations per day as of August 5, a 95% increase from July 5.